drugset / Trial / NCT02860507

Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency

NCT02860507

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of Sugammadex in rapidly reversing deep neuromuscular blockaded (induced by rocuronium)

Timeline

Start
2016-08
Primary completion
2018-02
Completion
2018-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.06 mg/kg Intravenous
Subject Sugammadex Other / unclassified 4 mg/kg
Comparator Glycopyrrolate Small molecule 0.04 mg/kg Intravenous

Indications

No indication recorded.